Shalini Sharp is listed as an executive officer and director on 9 SEC Form D filings by 1 issuer between Aug 2009 and Mar 2017: AGENUS INC (Lexington, MA — biotechnology — 2009–2017; $60M reported sold to 17 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Brian Corvese (9 shared filings), Christine M. Klaskin (9 shared filings), Garo H. Armen (9 shared filings), Karen Valentine (9 shared filings), Timothy Wright (9 shared filings) and 11 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Shalini. Each name links to their own page.
The issuer belongs to the sponsor group Agenus (2 issuers, $130M reported sold, 2009–2019).
What this means A sponsor group is one team that sets up a new company for each deal. Agenus has 2 companies on file and $130M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 9 public filings for Shalini Sharp and found 6 differences: No amendment in the last 12 months on an offering that may still be open; Shalini Sharp's role changed at AGENUS INC: executive officer → director; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.